Metabolic Disease

| 3 min read
Sagimet’s denifanstat delivered significant improvements in disease activity and fibrosis for patients with metabolic dysfunction-associated steatohepatitis.Page 1 of 1 - 6 Total Items


Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe